Template:ST elevation myocardial infarction: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 216: | Line 216: | ||
::[[ST elevation myocardial infarction glycoprotein IIbIIIa inhibition|Glycoprotein IIbIIIa Inhibition]] | ::[[ST elevation myocardial infarction glycoprotein IIbIIIa inhibition|Glycoprotein IIbIIIa Inhibition]] | ||
:Other Initial Therapy | :Other Initial Therapy | ||
::[[ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge|Inhibition of the Renin-Angiotensin-Aldosterone System]] | ::[[ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge|Inhibition of the Renin-Angiotensin-Aldosterone System]] | ||
::[[ST elevation myocardial infarction magnesium therapy|Magnesium Therapy]] | ::[[ST elevation myocardial infarction magnesium therapy|Magnesium Therapy]] |
Revision as of 15:46, 31 October 2016
ST Elevation Myocardial Infarction Microchapters |
Differentiating ST elevation myocardial infarction from other Diseases |
---|
Diagnosis |
Treatment |
|
Case Studies |
ST elevation myocardial infarction On the Web |
Directions to Hospitals Treating ST elevation myocardial infarction |
Risk calculators and risk factors for ST elevation myocardial infarction |